4//SEC Filing
GORMAN KEVIN CHARLES 4
Accession 0000914475-25-000031
CIK 0000914475other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:58 PM ET
Size
9.4 KB
Accession
0000914475-25-000031
Insider Transaction Report
Form 4
GORMAN KEVIN CHARLES
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-01-31−5,141→ 5,142 total→ Common Stock (5,141 underlying) - Sale
Common Stock
2025-01-31$152.92/sh−2,707$413,967→ 517,030 total - Exercise/Conversion
Common Stock
2025-01-31+5,141→ 519,737 total
Footnotes (5)
- [F1]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on September 1, 2022. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.85 to $154.03. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]514,596 of the outstanding shares are held by the Gorman and Blais Family Trust, of which Dr. Gorman has voting and investment power.
- [F4]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F5]This RSU was granted to the Reporting Person on January 31, 2022. In accordance with the terms of the RSU, the award vested as to 5,141 shares on January 31, 2023, vested as to 5,141 shares on January 31, 2024, vested as to 5,141 shares on January 31, 2025, and will vest as to 5,142 shares on January 31, 2026, subject to the terms and conditions of the award.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
Related Parties
1- filerCIK 0001201096
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:58 PM ET
- Size
- 9.4 KB